Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168052 | 0.89 | HDAC1 (0.63) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL6570646 | 0.88 | HDAC1 (0.61) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL2169842 | 0.88 | HDAC1 (0.61) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL6572367 | 0.88 | HDAC1 (0.61) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL28011647 | 0.87 | NAAA (0.52) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL18877141 | 0.86 | TRPA1 (0.49) | L3MBTL1NAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL4564262 | 0.84 | L3MBTL1 (0.59) | L3MBTL1NAAAGAASMN1; SMN2LMNA | |
| SCHEMBL668703 | 0.84 | L3MBTL1 (0.59) | L3MBTL1GAASMN1; SMN2LMNAPOLB | |
| SCHEMBL9188848 | 0.82 | HDAC8 (0.58) | HDAC8SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL24052293 | 0.82 | CA2 (0.50) | L3MBTL1HDAC2HDAC8HDAC6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108686634-B | Solid phase for mixed mode chromatographic purification of proteins | 生物辐射实验室股份有限公司 | 2021-03-16 | — | — | CN | claimed |
| US-20200391196-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | BIO RAD LABORATORIES (US) | 2020-12-17 | — | — | US | claimed |
| CN-108686634-A | The solid phase of hybrid chromatogram purification for protein | 生物辐射实验室股份有限公司 | 2018-10-23 | — | — | CN | claimed |
| EP-2768843-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | Bio-Rad Laboratories, Inc. (US) | 2014-08-27 | — | — | EP | claimed |
| CN-103998456-A | Solid phase for mixed mode chromatographic purification of proteins | BIO RAD LABORATORIES | 2014-08-20 | — | — | CN | claimed |
| US-20130102761-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | BIO-RAD LABORATORIES, INC. (US) | 2013-04-25 | — | — | US | claimed |
| WO-2013059690-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | BIO-RAD LABORATORIES, INC. (US) | 2013-04-25 | — | — | WO | claimed |
| EP-0867558-B1 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KK (JP) | 2006-10-18 | — | — | EP | claimed |
| US-6200667-B1 | INK-JET PRINTING A CLOTH OF COTTON OR SILK FIBER USING A REACTIVE DYE AND A COMPOUND(S) OF PYRIDINE-3-CARBOXYLIC ACID, BISHYDROXYETHYL-TAURINE, HIPPURIC ACID, BENZOYLTAURINE; NONBLEEDING COLOR INTENSITY; CLARITY | CANON KABUSHIKI KAISHA (JP) | 2001-03-13 | — | — | US | claimed |
| EP-0867558-A2 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KABUSHIKI KAISHA (JP) | 1998-09-30 | — | — | EP | claimed |
| US-11590486-B2 | Solid phase for mixed-mode chromatographic purification of proteins | BIO-RAD LABORATORIES, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| CN-108686634-B | Solid phase for mixed mode chromatographic purification of proteins | 生物辐射实验室股份有限公司 | 2021-03-16 | — | — | CN | disclosed |
| US-20200391196-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | BIO RAD LABORATORIES (US) | 2020-12-17 | — | — | US | disclosed |
| US-10792654-B2 | Solid phase for mixed-mode chromatographic purification of proteins | BIO-RAD LABORATORIES, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| CN-108686634-A | The solid phase of hybrid chromatogram purification for protein | 生物辐射实验室股份有限公司 | 2018-10-23 | — | — | CN | disclosed |
| US-20070111125-A1 | CHARGE CONTROLLING AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070111125-A1 | CHARGE CONTROLLING AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-0867558-B1 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KK (JP) | 2006-10-18 | — | — | EP | disclosed |
| US-6200667-B1 | INK-JET PRINTING A CLOTH OF COTTON OR SILK FIBER USING A REACTIVE DYE AND A COMPOUND(S) OF PYRIDINE-3-CARBOXYLIC ACID, BISHYDROXYETHYL-TAURINE, HIPPURIC ACID, BENZOYLTAURINE; NONBLEEDING COLOR INTENSITY; CLARITY | CANON KABUSHIKI KAISHA (JP) | 2001-03-13 | — | — | US | disclosed |
| EP-0867558-A2 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KABUSHIKI KAISHA (JP) | 1998-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10792654-B2 | Solid phase for mixed-mode chromatographic purification of proteins | AFG3L2, MRPL21, SSBP1 | L3MBTL1 2642/4885NAAA 1310/4885HDAC3 2582/4885 |
| US-20200391196-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | MRPL21, SCAMP2, AFG3L2 | L3MBTL1 2496/4885NAAA 3171/4885HDAC3 3366/4885 |
| US-20130102761-A1 | SOLID PHASE FOR MIXED-MODE CHROMATOGRAPHIC PURIFICATION OF PROTEINS | MRPL21, SCAMP2, AFG3L2 | L3MBTL1 2496/4885NAAA 3171/4885HDAC3 3366/4885 |
| US-11590486-B2 | Solid phase for mixed-mode chromatographic purification of proteins | SAMM50, MAX, RAB5IF | L3MBTL1 3473/4885NAAA 2293/4885HDAC3 4566/4885 |
| US-20070111125-A1 | CHARGE CONTROLLING AGENT AND TONER | CA2, ACTR2, CA12 | L3MBTL1 4774/4885NAAA 91/4885HDAC3 1039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.